{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:48:39Z","timestamp":1790833719227,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005694","name":"Hori Sciences And Arts Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.virol.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T15:11:58Z","timestamp":1613920318000},"page":"44-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells"],"prefix":"10.1016","volume":"557","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7121-9630","authenticated-orcid":false,"given":"Yusuke","family":"Yanagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3139-9272","authenticated-orcid":false,"given":"Yusuke","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8867-3669","authenticated-orcid":false,"given":"Yohei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0953-2471","authenticated-orcid":false,"given":"H.M. Abdullah Al","family":"Masud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teru","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8063-5660","authenticated-orcid":false,"given":"Hiroshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.virol.2021.02.004_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41375-018-0178-x","article-title":"Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas","volume":"33","author":"Anastasiadou","year":"2019","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.virol.2021.02.004_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF-\u03baB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma","volume":"9","author":"Bi","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.virol.2021.02.004_bib3","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1073\/pnas.100119497","article-title":"NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells","volume":"97","author":"Cahir-McFarland","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.virol.2021.02.004_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2018-02-833806","article-title":"Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?","volume":"132","author":"Carbone","year":"2018","journal-title":"Blood"},{"issue":"6282","key":"10.1016\/j.virol.2021.02.004_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.virol.2021.02.004_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.it.2017.01.002","article-title":"MYC: master regulator of immune privilege","volume":"38","author":"Casey","year":"2017","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.virol.2021.02.004_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/bioinformatics\/bth078","article-title":"Open source clustering software","volume":"20","author":"de Hoon","year":"2004","journal-title":"Bioinformatics"},{"issue":"14","key":"10.1016\/j.virol.2021.02.004_bib8","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.95.14.8245","article-title":"Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells","volume":"95","author":"Delecluse","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2021.02.004_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.humpath.2016.02.007","article-title":"Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma","volume":"53","author":"Dong","year":"2016","journal-title":"Hum. Pathol."},{"issue":"Pt 1","key":"10.1016\/j.virol.2021.02.004_bib10","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"6","key":"10.1016\/j.virol.2021.02.004_bib11","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/v5061587","article-title":"NF-\u03baB and IRF7 pathway activation by Epstein-Barr virus latent membrane protein 1","volume":"5","author":"Ersing","year":"2013","journal-title":"Viruses"},{"issue":"23","key":"10.1016\/j.virol.2021.02.004_bib12","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.18632\/oncotarget.2608","article-title":"EBV-driven LMP1 and IFN-\u03b3 up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.virol.2021.02.004_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00478-18","article-title":"Regulation of Epstein-Barr virus life cycle and cell proliferation by histone H3K27 methyltransferase EZH2 in Akata cells","volume":"3","author":"Ichikawa","year":"2018","journal-title":"mSphere"},{"issue":"4","key":"10.1016\/j.virol.2021.02.004_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.chom.2017.09.001","article-title":"The Epstein-Barr virus regulome in lymphoblastoid cells","volume":"22","author":"Jiang","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.virol.2021.02.004_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/jvi.69.1.253-262.1995","article-title":"Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1","volume":"69","author":"Johannsen","year":"1995","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2021.02.004_bib16","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/JVI.73.5.4481-4484.1999","article-title":"The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2","volume":"73","author":"Kaiser","year":"1999","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2021.02.004_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejcb.2011.01.014","article-title":"Human B cells on their route to latent infection\u2014early but transient expression of lytic genes of Epstein-Barr virus","volume":"91","author":"Kalla","year":"2012","journal-title":"Eur. J. Cell Biol."},{"issue":"7","key":"10.1016\/j.virol.2021.02.004_bib18","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41375-019-0380-5","article-title":"Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas","volume":"33","author":"Kataoka","year":"2019","journal-title":"Leukemia"},{"issue":"Pt 10","key":"10.1016\/j.virol.2021.02.004_bib19","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1099\/vir.0.012831-0","article-title":"Quantitative evaluation of the role of Epstein-Barr virus immediate-early protein BZLF1 in B-cell transformation","volume":"90","author":"Katsumura","year":"2009","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.virol.2021.02.004_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/10428194.2018.1480767","article-title":"Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation","volume":"60","author":"Kinch","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"19","key":"10.1016\/j.virol.2021.02.004_bib21","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","article-title":"Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma","volume":"126","author":"Kiyasu","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.virol.2021.02.004_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00138-18","article-title":"BGLF2 increases infectivity of Epstein-Barr virus by activating AP-1","volume":"3","author":"Konishi","year":"2018","journal-title":"mSphere"},{"issue":"11","key":"10.1016\/j.virol.2021.02.004_bib23","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1073\/pnas.0813134106","article-title":"Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth","volume":"106","author":"Maruo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"32","key":"10.1016\/j.virol.2021.02.004_bib24","doi-asserted-by":"crossref","first-page":"16046","DOI":"10.1073\/pnas.1901314116","article-title":"Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection","volume":"116","author":"Mrozek-Gorska","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.virol.2021.02.004_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/1348-0421.12155","article-title":"Regulation of Epstein-Barr virus reactivation from latency","volume":"58","author":"Murata","year":"2014","journal-title":"Microbiol. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.virol.2021.02.004_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.virol.2009.04.007","article-title":"Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase","volume":"389","author":"Murata","year":"2009","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2021.02.004_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/rmv.1786","article-title":"Modes of infection and oncogenesis by the Epstein-Barr virus","volume":"24","author":"Murata","year":"2014","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"10.1016\/j.virol.2021.02.004_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211358","article-title":"Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma","volume":"14","author":"Nakayama","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.virol.2021.02.004_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/gene.2011.21","article-title":"IRF7: activation, regulation, modification and function","volume":"12","author":"Ning","year":"2011","journal-title":"Gene Immun."},{"issue":"3","key":"10.1016\/j.virol.2021.02.004_bib30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein-Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"3","key":"10.1016\/j.virol.2021.02.004_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004656","article-title":"To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis","volume":"11","author":"Price","year":"2015","journal-title":"PLoS Pathog."},{"issue":"20","key":"10.1016\/j.virol.2021.02.004_bib32","doi-asserted-by":"crossref","first-page":"11096","DOI":"10.1128\/JVI.01069-12","article-title":"Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-\u03baB activation","volume":"86","author":"Price","year":"2012","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2021.02.004_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01178-17","article-title":"c-Myc represses transcription of Epstein-Barr virus latent membrane protein 1 early after primary B cell infection","volume":"92","author":"Price","year":"2018","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.virol.2021.02.004_bib34","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1093\/bioinformatics\/bth349","article-title":"Java Treeview\u2014extensible visualization of microarray data","volume":"20","author":"Saldanha","year":"2004","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.virol.2021.02.004_bib35","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1469-0691.2009.03033.x","article-title":"Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma","volume":"15","author":"Shah","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.virol.2021.02.004_bib36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.virol.2021.02.004_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02155-17","article-title":"Epstein-Barr virus nuclear antigen leader protein coactivates EP300","volume":"92","author":"Wang","year":"2018","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.virol.2021.02.004_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00226-19","article-title":"RNA sequencing analyses of gene expression during Epstein-Barr virus infection of primary B lymphocytes","volume":"93","author":"Wang","year":"2019","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2021.02.004_bib39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cmet.2019.06.003","article-title":"Epstein-Barr-virus-induced one-carbon metabolism drives B cell transformation","volume":"30","author":"Wang","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.virol.2021.02.004_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18270","article-title":"MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs","volume":"5","author":"Wood","year":"2016","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.virol.2021.02.004_bib41","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1073\/pnas.0510612103","article-title":"RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines","volume":"103","author":"Zhao","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"36","key":"10.1016\/j.virol.2021.02.004_bib42","doi-asserted-by":"crossref","first-page":"14902","DOI":"10.1073\/pnas.1108892108","article-title":"Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth","volume":"108","author":"Zhao","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682221000386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682221000386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:54:23Z","timestamp":1758588863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682221000386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":42,"alternative-id":["S0042682221000386"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2021.02.004","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}